@article{kosiborod2021dapagliflozin,
  title={Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial},
  author={Kosiborod, Mikhail N and Esterline, Russell and Furtado, Remo HM and Oscarsson, Jan and Gasparyan, Samvel B and Koch, Gary G and Martinez, Felipe and Mukhtar, Omar and Verma, Subodh and Chopra, Vijay and others},
  journal={The Lancet Diabetes \& Endocrinology},
  volume={9},
  number={9},
  pages={586--594},
  year={2021},
  publisher={Elsevier}
}